Skip to content

A study to Compare Endotracheal Tube and LMA Protector in patients posted for Laproscopic Cholecystectomy.

COMPARISON OF PROTECTOR LMA AND ENDOTRACHEAL TUBE IN PATIENT UNDERGOING LAPROSCOPIC CHOLECYSTECTOMY: A RADOMISED CONTROLLED TRIAL.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/079980
Enrollment
96
Registered
2025-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R10-R19- Symptoms and signs involving the digestive system and abdomen

Interventions

Intervention1: Endotracheal tube: Endotracheal tube of appropriate size will be used to secure airway after preoxygenation of 3 minutes Control Intervention1: LMA Protector: LMA protector of appropria

Sponsors

Dr Lakesh k Anand
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiologists (ASA) physical status I-II, Patients undergoing elective laparoscopic cholecystectomy surgeries requiring General anaesthesia.

Exclusion criteria

Exclusion criteria: 1.Patients with a body mass index (BMI)more than 35 kg per meter square. 2.Patients with increased risk of regurgitation and aspiration of gastric content 3.Patients with distorted airway anatomy 4.Patients with upper respiratory tract infection 5.Patients with hepatic or renal insufficiency 6.Pregnant patients 7.Patients unable to understand the study protocol 8.Refusal of consent

Design outcomes

Primary

MeasureTime frame
Hemodynamic response (Heart rate and Blood pressure)Timepoint: Hemodynamic response (Heart rate and Blood pressure) will be recorded at fixed time intervals Preinduction, after induction with the LMA Protector or ETT, before pneumo-peritoneum 1, 5, 10 minutes after pneumoperitoneum after release of pneumoperitoneum during extubation and postoperatively at 0 hour (when patient is conscious, oriented and able to comprehend) and at 24 hours.

Secondary

MeasureTime frame
Postoperative laryngopharyngeal morbidity (Sore throat & dysphagia)Timepoint: Post extubation & after 24 hours

Countries

India

Contacts

Public ContactLakesh kumar Anand

MM Institute of Medical Science and Research, Mullana, Ambala

lkanand11@yahoo.com9646121522

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026